Difference between revisions of "Srivastava A, et al. J. Biomed. Nanotechnol. (2016) cited as Ref 545 in DOI: 10.1038/s41392-020-0110-5 (Q9808)"
Jump to navigation
Jump to search
(Created claim: Volume (P103): 12, #quickstatements; #temporary_batch_1590009084631) |
(Created claim: title (P93): Exploitation of exosomes as nanocarriers for gene- chemo- and immune-therapy of cancer, #quickstatements; #temporary_batch_1590010982689) |
||
| Property / title | |||
| + | Exploitation of exosomes as nanocarriers for gene- chemo- and immune-therapy of cancer (English) | ||
| Property / title: Exploitation of exosomes as nanocarriers for gene- chemo- and immune-therapy of cancer (English) / rank | |||
| + | Normal rank | ||
Revision as of 22:04, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Srivastava A, et al. J. Biomed. Nanotechnol. (2016) cited as Ref 545 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Srivastava A
0 references
2016
0 references
J. Biomed. Nanotechnol.
0 references
12
0 references
Exploitation of exosomes as nanocarriers for gene- chemo- and immune-therapy of cancer (English)
0 references
